[Probiotics--should we change the treatment strategy for pouchitis?]

Ugeskr Laeger. 2006 Oct 9;168(41):3516-8.
[Article in Danish]

Abstract

Pouchitis is an idiopathic inflammatory bowel disease, which occurs in up to 50% of patients operated on for ulcerative colitis with ileal pouch-anal anastomosis (IPAA). Treatment of pouchitis is still to a large extent empirical, but recently more randomized, double-blind placebo-controlled trials have been conducted. This article reviews the possible treatments for pouchitis, focusing especially on treatment with probiotics, which seem to be a new and promising alternative to antibiotics. We are currently doing clinical trials to determine whether a probiotic is an effective treatment for chronic inflammatory bowel disease.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents / therapeutic use
  • Ciprofloxacin / therapeutic use
  • Evidence-Based Medicine
  • Humans
  • Metronidazole / therapeutic use
  • Pouchitis / drug therapy
  • Pouchitis / therapy*
  • Practice Guidelines as Topic
  • Probiotics / therapeutic use*
  • Recurrence

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Metronidazole
  • Ciprofloxacin